- Home
- AKRO vs CAKE Comparison
AKRO vs CAKE Comparison
Compare AKRO & CAKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- CAKE
- Stock Information
- Founded
- AKRO 2017
- CAKE 1972
- Country
- AKRO United States
- CAKE United States
- Employees
- AKRO N/A
- CAKE N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- CAKE Restaurants
- Sector
- AKRO Health Care
- CAKE Consumer Discretionary
- Exchange
- AKRO Nasdaq
- CAKE Nasdaq
- Market Cap
- AKRO 2.8B
- CAKE 2.4B
- IPO Year
- AKRO 2019
- CAKE 1992
- Fundamental
- Price
- AKRO $39.85
- CAKE $50.13
- Analyst Decision
- AKRO Strong Buy
- CAKE Hold
- Analyst Count
- AKRO 9
- CAKE 15
- Target Price
- AKRO $76.29
- CAKE $51.80
- AVG Volume (30 Days)
- AKRO 1.1M
- CAKE 1.3M
- Earning Date
- AKRO 05-16-2025
- CAKE 04-30-2025
- Dividend Yield
- AKRO N/A
- CAKE 2.15%
- EPS Growth
- AKRO N/A
- CAKE 45.67
- EPS
- AKRO N/A
- CAKE 3.19
- Revenue
- AKRO N/A
- CAKE $3,617,673,000.00
- Revenue This Year
- AKRO N/A
- CAKE $7.69
- Revenue Next Year
- AKRO N/A
- CAKE $6.17
- P/E Ratio
- AKRO N/A
- CAKE $15.74
- Revenue Growth
- AKRO N/A
- CAKE 4.42
- 52 Week Low
- AKRO $17.86
- CAKE $33.50
- 52 Week High
- AKRO $58.40
- CAKE $57.32
- Technical
- Relative Strength Index (RSI)
- AKRO 44.56
- CAKE 52.98
- Support Level
- AKRO $41.60
- CAKE $48.57
- Resistance Level
- AKRO $46.47
- CAKE $51.02
- Average True Range (ATR)
- AKRO 2.26
- CAKE 1.78
- MACD
- AKRO 0.08
- CAKE 0.08
- Stochastic Oscillator
- AKRO 21.84
- CAKE 57.54
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About CAKE Cheesecake Factory Incorporated (The)
Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.